Document is current
Any future updates will be listed below
-
Authors
Al-Mashhadi, Zheer K https://orcid.org/0000-0003-1201-199X
Viggers, Rikke
Starup-Linde, Jakob
Langdahl, Bente L
van Hulten, Veerle
van den Bergh, Joop P
Driessen, Johanna HM
Vestergaard, Peter
Gregersen, Søren
-
Funding
Funding for this research was provided by:
Aarhus University Hospital
- License Information
-
More Information
Article History
Received: 1 October 2025
Accepted: 14 August 2026
First Online: 11 September 2026
Declarations
Conflict of interest: Zheer K Al-Mashhadi, Veerle van Hulten, Johanna HM Driessen, Peter Vestergaard and Søren Gregersen declare that they have no conflicts of interest. Unrelated to this work, the remaining authors declare the following:following; Rikke Viggers declares that she holds stock in Eli Lilly and Novo Nordisk; Jakob Starup Linde declares that he is a speaker for UCB Nordic and Gedeon Richter; Bente L Langdahl declares advisory boards and lecture fees from UCB, Amgen, Gedeon Richter, Sandoz, Samsung-Bioepis, Mereo, Medivir, Entera-Bio, and Angitia; Joop P van den Bergh has received speaker honorarium from UCB and honorarium for consultation from Theramex and POROUS.
